March 28, 2025, in Copenhagen – CS MEDICA A/S (”CS MEDICA” or the ”Company”) held its annual general meeting (“AGM”) at which the following principal resolutions were passed.

1. Election of chairman of the meeting
The board proposed Gitte Lund Henriksen as chairman of the meeting, which was unanimously accepted by the attendees.

The chairman confirmed that the convening of the Annual General Meeting (AGM) complied with the company’s Articles of Association, as stipulated in section 5.1. Notice of the AGM was duly dispatched on the 13th of February 2025, meeting the requirements of section 5.2.

It was ascertained that the total number of voting shares stood at 11.332.682 (66%),  out of a total share count of 17.125.827.

2. Presentation of the annual report with auditors’ report for adoption
The AGM resolved in accordance with the Board of Directors’ proposal, to approve the annual report presented during the AGM, with all votes represented at the AGM.

The final signed annual report is enclosed in this press release.

3. Resolution concerning the appropriation of profits or losses as recorded in the adopted annual report
The AGM resolved, in accordance with the Board of Directors’ proposal, that the result for the period 1 October 2023 – 30 September 2024 (DKK – 9.650.907 ) is carried forward to the following year, with all votes represented at the AGM.

4. Election of members to the board of directors
The General Meeting resolved to replace the Board of Directors. The two founders, Lone Henriksen and Gitte Henriksen, together with Mads Jørgensen, were appointed as new board members, with Gitte Henriksen serving as Chair of the Board. The appointments are temporary and will remain in effect until a potential relisting of the company. The decision was unanimously approved by all votes represented at the General Meeting.

5. Election of auditor
The AGM resolved, in accordance with the board of directors’ proposal, that the existing auditor Christensen Kjærulff Statsautoriseret Revisionsaktieselskab was re-elected. The decision was supported by all votes represented at the AGM.

6. Amendment of the Articles of Association (Section 6.1)
The General Meeting unanimously approved the amendment to Section 6.1 of the Articles of Association, as proposed by the Board of Directors. The current wording: ‘The board of directors consists of no less than four and no more than eight members elected by the general meeting,’ was changed to: ‘The board of directors consists of no less than three and no more than eight members elected by the general meeting.’

The Chairman ascertained that no other business was to be discussed.

For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/
About CS MEDICA A/S
Founded in 2011, CS MEDICA is a Danish MedTech company specializing in CBD-infused treatments for autoimmune and stress-related conditions, including arthritis, psoriasis, and pain management. Operating at the intersection of the pharmaceutical and cosmetics industries, CS MEDICA delivers clinically supported products with fewer side effects, offering competitive and accessible alternatives. With MDR-approved products, cutting-edge R&D, and the benefits of CBD, the company provides innovative, safe, and effective solutions. Its capital-light business model and trusted European production partners further enhance its ability to offer high-quality treatments, setting CS MEDICA apart in the MedTech sector.